Nonetheless, how HMGB1 expression and release (active or passive) is enhanced in NAFLD is less clear, and whether the extracellular HMGB1 affects the downstream liver pathologies other than inflammation, such as hepatic fibrosis or ductular reactions, has not been examined (Figure 3). Here, HMGB1 is linked to Hepatic fibrosis.